Helmholtz Zentrum München, Institute of Epidemiology II, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Eur J Endocrinol. 2012 Sep;167(3):363-71. doi: 10.1530/EJE-12-0111. Epub 2012 Jun 13.
To investigate regional variations in the frequency of undiagnosed thyroid disorders among 25- to 88-year-old men and women in two communities in the northeast and the south of Germany. In addition, autoantibodies to thyroperoxidase (TPO-Abs) and urinary iodine excretion were determined.
Two population-based surveys of men and women using a common standardized protocol, the Study of Health in Pomerania (SHIP) in the northeast of Germany (2505 participants) and the Kooperative Gesundheitsforschung in der Region Augsburg (KORA) in the south of Germany (2316 participants), were compared with regard to the frequency of undiagnosed thyroid disorders.
Compared with the northeast of Germany, urinary iodine excretion and serum thyroid-stimulating hormone (TSH) levels were significantly higher in the south. The median urinary iodine concentration was 110 μg/l (64; 169 μg/l) in SHIP and 151 μg/l (97; 214 μg/l) in KORA, and the median TSH value was 0.81 mIU/l (0.56; 1.15 mIU/l) in SHIP and 1.22 mIU/l (0.84; 1.80 mIU/l) in KORA. The frequency of elevated TSH (TSH ≥ 2.12 mIU/l) was 4.3% in SHIP and 14.1% in KORA (P<0.001); the corresponding values for suppressed TSH (<0.25 mIU/l) were 3.5 and 1.7% (P<0.001). The proportion of ultrasonographic findings was 55.5% in SHIP and 68.0% in KORA. The frequency of serum TPO-Abs did not differ significantly between northeast and south Germany.
There were considerable regional disparities in the frequency of thyroid disorders within Germany. These differences can be explained not only by different regional histories of natural iodine deficiency but also by current differences in the iodine supply under an identical nationwide iodine fortification program.
研究德国东北部和南部两个社区 25 至 88 岁男性和女性中未确诊甲状腺疾病的频率存在地域差异。此外,还测定了甲状腺过氧化物酶抗体(TPO-Abs)和尿碘排泄量。
使用相同的标准化方案,对德国东北部的波罗的海健康研究(SHIP)(2505 名参与者)和德国南部的奥格斯堡合作健康研究(KORA)(2316 名参与者)进行了两项基于人群的调查,比较了未确诊甲状腺疾病的频率。
与德国东北部相比,南部的尿碘排泄量和血清促甲状腺激素(TSH)水平显著更高。SHIP 的中位数尿碘浓度为 110μg/l(64;169μg/l),KORA 的中位数尿碘浓度为 151μg/l(97;214μg/l),SHIP 的中位数 TSH 值为 0.81mIU/l(0.56;1.15mIU/l),KORA 的中位数 TSH 值为 1.22mIU/l(0.84;1.80mIU/l)。SHIP 的 TSH 升高频率(TSH≥2.12mIU/l)为 4.3%,KORA 的 TSH 升高频率为 14.1%(P<0.001);TSH 降低频率(<0.25mIU/l)分别为 3.5%和 1.7%(P<0.001)。SHIP 的超声检查结果比例为 55.5%,KORA 的超声检查结果比例为 68.0%。德国东北部和南部的血清 TPO-Abs 频率无显著差异。
德国境内甲状腺疾病的频率存在相当大的地域差异。这些差异不仅可以归因于自然碘缺乏症的不同地区历史,还可以归因于在相同的全国性碘强化计划下,目前碘供应的差异。